Physician profile
William E Hogancamp
NPI 1164432613
$7,832.75
in general payments reported to CMS, 2019-2025
49 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,897 · 2020: $1,358 · 2021: $916 · 2022: $1,146 · 2023: $1,670 · 2024: $399 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Education: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,199.68 |
| Education | $316.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,226.77 | 2019-2021 | |
| Abbvie INC. | $1,008.55 | 2021-2025 | |
| Pfizer INC. | $563.44 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $537.03 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $321.26 | 2019-2023 | Ultomiris, Soliris |
| Celgene Corporation | $296.57 | 2021-2023 | Zeposia |
| Biogen, INC. | $266.18 | 2019-2025 | Vumerity, Skyclarys |
| Teva Pharmaceuticals USA, INC. | $264.41 | 2019-2023 | Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $257.54 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $228.01 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $187.10 | 2020-2025 | |
| Avanir Pharmaceuticals, INC. | $186.61 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $185.30 | 2019-2021 | |
| Inspire Medical Systems, INC. | $184.63 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company Ltd. | $176.20 | 2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hogancamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.